|
| |
Image Results
Loading...
Loading...
Vaccinex Incorporated Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
VACCINEX, INC - NIH Research Portfolio Online Reporting Tool (RePORT)
Please see the contact information at the bottom of this page if you have comments or questions relating to the data provided. Detail for: VACCINEX, INC. ...
http://report.nih.gov/award/trends/FindOrg_Detail.cfm?OrgID=...
|
{1} And Biocon To Co-Develop Antibody Pr - News, Search Jobs ...
18 /PRNewswire/ -- Vaccinex, Inc. and Biocon Limited today announced a broad strategic partnership to discover and co-develop at least four therapeutic ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1818582...
|
CBET Home Page- Center for Bioscience Education & Technology ...
The vaccine developer Vaccinex Inc. wished to hire a group of people being downsized by a pharmaceutical company that was relocating. ...
http://www.rit.edu/cos/cbet/ws/biotech.php...
|
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in ...
Vaccinex, Inc., Rochester, 1875 Mt. Hope Avenue, Rochester, NY 14620, USA. eevans@vaccinex.com. Identification of shared tumor-specific targets is useful in ...
http://www.ncbi.nlm.nih.gov/pubmed/17121940...
|
Connections: The University of Rochester and the Community
Vaccinex, Inc., president and CEO Maurice Zauderer, right, at work in an immunology lab. Zauderer—associate professor of oncology in microbiology and ...
http://www.rochester.edu/aboutus/connections/development.htm...
|
Lethality-based selection of recombinant genes in mammalian cells ...
1 Vaccinex, Inc., Rochester, New York, USA. 2 Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, ...
http://www.nature.com/nm/journal/v7/n8/abs/nm0801_967.html...
|
Lethality-based selection of recombinant genes in mammalian cells ...
Vaccinex, Inc., Rochester, New York, USA. Many biological processes result in either cell death or cessation of cell growth. ...
http://www.ncbi.nlm.nih.gov/pubmed/11479631...
|
Biodefense SBIR Awards, NIAID, NIH
20 Dec 2006 ... Vaccinex, Inc. Ernest Smith, Human Monoclonal Antibodies for Bioterrorism Defense. Vaxinnate Corporation, Thomas Powell, Discovery of Novel ...
http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefens...
|
Construction of cDNA libraries in vaccinia virus.
Vaccinex, Inc, Rochester, New York, USA. Poxvirus expression vectors have gained widespread use for expression of foreign proteins and as delivery vehicles ...
http://www.ncbi.nlm.nih.gov/pubmed/15114008...
|
A Single Amino Acid Change in the L-Polymerase Protein of ...
†Present address: Vaccinex, Inc., Rochester, NY 14620. Received November 9, 2004 ; Accepted February 8, 2005. Small right arrow pointing to: ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=11...
|
|